Skip to main content

Table 1 Evaluation of r-Δgp160-based TRF assays using HIV-1 seroconversion panel (PRB 931)

From: Escherichia coli–expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen

Member ID#

Days since 1stbleed

Abbott

Gen. Sys.

Organon Teknika HIVa

TRF assaysb

HIV1a

HIV1/2a

HIV1a

HIV1/2a

r-Δgp160 two-step

r-Δgp160 one-step

01

0

0.2

0.1

0.2

0.1

0.3

0.9 (−)

0.5 (−)

02

2

0.2

0.1

0.1

0.1

0.3

0.8 (−)

0.5 (−)

03

7

0.2

0.1

0.2

0.1

0.4

0.8 (−)

0.4 (−)

04

9

0.2

0.1

0.2

0.1

0.3

0.8 (−)

0.5 (−)

05

15

0.2

0.1

0.2

0.1

0.3

0.7 (−)

0.5 (−)

06

28

0.9

6

0.3

0.4

0.6

17.2 (+)

5.6 (+)

07

33

3.9

>18.7

0.8

1.1

2.3

15.9 (+)

4.3 (+)

08

35

5.7

>18.7

1.3

1.9

3.1

11.9 (+)

3.3 (+)

09

42

10.5

>18.7

2.9

4

4.6

13.8 (+)

2.9 (+)

  1. aValues indicate S/Co ratios, provided by the panel supplier using the indicated commercial EIA kits. S/Co values ≥ 1.0 are considered as positive.
  2. bValues indicate S/Co ratios obtained using r-Δgp160-based TRF assays. The results are indicated in parentheses. Samples with S/Co values < 1.0 are designated as negative (−) and those with values ≥ 1.0 are designated as positive (+).